GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-cola Euro. Regulatory News (CCEP)

Share Price Information for Coca-cola Euro. (CCEP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 68.20
Bid: 66.80
Ask: 68.80
Change: 0.40 (0.59%)
Spread: 2.00 (2.994%)
Open: 66.80
High: 68.20
Low: 66.80
Prev. Close: 67.80
CCEP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual report on remuneration 2019 - correction

1 May 2020 16:30

RNS Number : 7150L
Coca-Cola European Partners plc
01 May 2020
 

LONDON, 1 May 2020

 

COCA-COLA EUROPEAN PARTNERS

 

Correction to Annual report on remuneration

This is a correction to the disclosure in the 2019 Annual Report on Remuneration. It corrects the illustration of the 2019 Long-Term Incentive Plan vesting schedule.

Further to the publication of the Integrated Report for the financial year ended 31 December 2019 for Coca-Cola European Partners plc (the "Company") on 16 March 2020, the Company seeks to correct a typographical error in the illustration of the vesting schedule for Long-Term Incentive Plan ("LTIP") awards granted in 2019 on page 100, within the Annual report on remuneration.

The vesting levels included in the table heading row were incorrect. The full corrected table is presented below.

The vesting of awards is subject to the achievement of the following performance targets:

Vesting level (% of Target)(C)

Measure

Definition

Weighting

Threshold(25% vesting)

Target(100% vesting)

Maximum(200% vesting)

EPS(A)

Compound annual growth over the three year period 2019-2021

50%

5.7% p.a.

11.0% p.a.

15.5% p.a.

ROIC(B)

ROIC achieved in the final year of the performance period (2021)

50%

10.9%

12.4%

13.9%

(A) Comparable and on a tax and currency neutral basis. Targets include the impact of share buybacks to provide greater alignment with external expectations. The targets have been set based on current assumptions in respect of share buybacks over the performance period. The final performance targets will be adjusted to reflect the actual value of share buybacks made during the performance period to neutralise any variances and will be fully disclosed at the time of vesting.

(B) ROIC calculated as comparable operating profit after tax, on a tax and currency neutral basis, divided by the average of opening and closing invested capital for the year. Invested capital is calculated as the addition of borrowings and equity less cash and cash equivalents. For the purpose of these awards, invested capital excludes the effect of the Group's adoption of IFRS 16 on 1 January 2019.

(C) Straight-line vesting between each vesting level (shown).

Note that the equivalent table included on page 86 of the 2018 Integrated Report correctly disclosed the vesting schedule for the 2019 LTIP.

 

CONTACTS

 

Company Secretariat

Clare Wardle

T +44 20 7355 8406

Investor Relations

Sarah Willett

+44 7970 145 218

Media Relations

Shanna Wendt

T +44 7976 595 168

 

 

ABOUT CCEP

Coca-Cola European Partners plc is a leading consumer goods company in Western Europe, making, selling and distributing an extensive range of non-alcoholic ready-to-drink beverages and is the world's largest Coca-Cola bottler based on revenue. Coca-Cola European Partners serves a consumer population of over 300 million across Western Europe, including Andorra, Belgium, continental France, Germany, Great Britain, Iceland, Luxembourg, Monaco, the Netherlands, Norway, Portugal, Spain and Sweden. The Company is listed on Euronext Amsterdam, the New York Stock Exchange, London Stock Exchange and on the Spanish Stock Exchanges, trading under the symbol CCEP.

 

For more information about CCEP, please visit our website at www.ccep.com and follow CCEP on Twitter at @CocaColaEP.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FURKZGGKDMFGGZM
Date   Source Headline
25th Jul 20234:00 pmRNSDirector/PDMR Shareholding
21st Jul 20232:30 pmRNSDirector/PDMR Shareholding
13th Jul 20233:30 pmRNSDirector/PDMR Shareholding
30th Jun 20234:30 pmRNSDirector/PDMR Shareholding
23rd Jun 20233:00 pmRNSDirector/PDMR Shareholding
8th Jun 202310:50 amRNSDirector/PDMR Shareholding
1st Jun 20232:15 pmRNSTotal Voting Rights
26th May 20234:30 pmRNSDirector/PDMR Shareholding
25th May 202311:30 amRNSResult of AGM
23rd May 20233:00 pmRNSDirector/PDMR Shareholding
18th May 202311:30 amRNSDirector/PDMR Shareholding
15th May 20233:30 pmRNSLetter to Shareholders
4th May 20234:00 pmRNSDirector/PDMR Shareholding
2nd May 20232:45 pmRNSTotal Voting Rights
25th Apr 20237:00 amRNSQ1 Trading Update & Interim Dividend Declaration
21st Apr 20234:58 pmRNSDirector/PDMR Shareholding
14th Apr 20231:30 pmRNSDirector/PDMR Shareholding
12th Apr 20239:00 amRNSNotice of AGM
3rd Apr 20232:45 pmRNSTotal Voting Rights
22nd Mar 202311:45 amRNSDirector/PDMR Shareholding
22nd Mar 202311:45 amRNSDirector/PDMR Shareholding
17th Mar 20233:30 pmRNSBlock listing Interim Review
17th Mar 202311:55 amRNSAnnual Financial Report
14th Mar 20239:45 amRNSDirector/PDMR Shareholding
13th Mar 20234:35 pmRNSPrice Monitoring Extension
3rd Mar 20233:50 pmRNSDirector/PDMR Shareholding
1st Mar 20233:20 pmRNSTotal Voting Rights
23rd Feb 202310:30 amRNSDirector/PDMR Shareholding
16th Feb 20237:00 amRNSPreliminary Unaudited Results Q4 & FY 2022
15th Feb 20234:35 pmRNSPrice Monitoring Extension
15th Feb 202310:00 amRNSDirectorate Change
1st Feb 20233:30 pmRNSTotal Voting Rights
23rd Jan 20234:30 pmRNSDirector/PDMR Shareholding
16th Jan 20232:30 pmRNSDirector/PDMR Shareholding
3rd Jan 20232:40 pmRNSTotal Voting Rights
21st Dec 20223:45 pmRNSDirector/PDMR Shareholding
1st Dec 20223:15 pmRNSTotal Voting Rights
23rd Nov 20228:00 amRNSDirector/PDMR Shareholding
15th Nov 20225:30 pmRNSDirector/PDMR Shareholding
4th Nov 20225:20 pmRNSDirector/PDMR Shareholding
2nd Nov 20227:00 amRNSQ3, Investor Event & Interim Dividend Declaration
1st Nov 20223:45 pmRNSTotal Voting Rights
21st Oct 20223:00 pmRNSDirector/PDMR Shareholding
14th Oct 20222:30 pmRNSDirector/PDMR Shareholding
3rd Oct 20222:30 pmRNSTotal Voting Rights
22nd Sep 20223:00 pmRNSDirector/PDMR Shareholding
20th Sep 202210:00 amRNSBlock listing Interim Review
16th Sep 20224:36 pmRNSPrice Monitoring Extension
9th Sep 20224:36 pmRNSPrice Monitoring Extension
9th Sep 20223:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.